Denali Therapeutics Inc. (DNLI)

Denali Therapeutics Statistics

Total Valuation

DNLI has a market cap or net worth of $2.53 billion. The enterprise value is $1.60 billion.

Market Cap	2.53B
Enterprise Value	1.60B

Important Dates

The next estimated earnings date is Wednesday, November 5, 2025, after market close.

Earnings Date	Nov 5, 2025
Ex-Dividend Date	n/a

Share Statistics

DNLI has 146.42 million shares outstanding. The number of shares has increased by 14.84% in one year.

Current Share Class	146.42M
Shares Outstanding	146.42M
Shares Change (YoY)	+14.84%
Shares Change (QoQ)	+0.13%
Owned by Insiders (%)	4.79%
Owned by Institutions (%)	94.54%
Float	132.25M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
Forward PS	n/a
PB Ratio	2.45
P/TBV Ratio	2.46
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 10.27, with a Debt / Equity ratio of 0.05.

Current Ratio	10.27
Quick Ratio	9.89
Debt / Equity	0.05
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	-313.87

Financial Efficiency

Return on equity (ROE) is -39.69% and return on invested capital (ROIC) is -26.56%.

Return on Equity (ROE)	-39.69%
Return on Assets (ROA)	-24.99%
Return on Invested Capital (ROIC)	-26.56%
Return on Capital Employed (ROCE)	-49.63%
Revenue Per Employee	n/a
Profits Per Employee	-$1.14M
Employee Count	422
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

In the past 12 months, DNLI has paid $68,000 in taxes.

Income Tax	68,000
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -37.48% in the last 52 weeks. The beta is 1.29, so DNLI's price volatility has been higher than the market average.

Beta (5Y)	1.29
52-Week Price Change	-37.48%
50-Day Moving Average	14.82
200-Day Moving Average	15.81
Relative Strength Index (RSI)	68.28
Average Volume (20 Days)	1,895,765

Short Selling Information

The latest short interest is 14.15 million, so 9.66% of the outstanding shares have been sold short.

Short Interest	14.15M
Short Previous Month	13.08M
Short % of Shares Out	9.66%
Short % of Float	10.70%
Short Ratio (days to cover)	5.78

Income Statement

Revenue	n/a
Gross Profit	-396.06M
Operating Income	-533.58M
Pretax Income	-478.97M
Net Income	-479.03M
EBITDA	-529.42M
EBIT	-533.58M
Earnings Per Share (EPS)	-$2.81

Balance Sheet

The company has $898.95 million in cash and $47.97 million in debt, giving a net cash position of $929.44 million or $6.35 per share.

Cash & Cash Equivalents	898.95M
Total Debt	47.97M
Net Cash	929.44M
Net Cash Per Share	$6.35
Equity (Book Value)	1.03B
Book Value Per Share	7.05
Working Capital	843.65M

Cash Flow

In the last 12 months, operating cash flow was -$349.62 million and capital expenditures -$18.33 million, giving a free cash flow of -$367.95 million.

Operating Cash Flow	-349.62M
Capital Expenditures	-18.33M
Free Cash Flow	-367.95M
FCF Per Share	-$2.51

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

DNLI does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-14.84%
Shareholder Yield	-14.84%
Earnings Yield	-18.97%
FCF Yield	-14.57%

Analyst Forecast

The average price target for DNLI is $33.50, which is 94.20% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$33.50
Price Target Difference	94.20%
Analyst Consensus	Strong Buy
Analyst Count	14
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	-32.47%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	1